Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Gali Epstein Shochet"'
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 15, p 12393 (2023)
The ECM propagates processes in idiopathic pulmonary fibrosis (IPF), leading to progressive lung scarring. We established an IPF-conditioned matrix (IPF-CM) system as a platform for testing drug candidates. Here, we tested the involvement of a PGE2 a
Externí odkaz:
https://doaj.org/article/567b92c41e2a4db09d461733aab79cba
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease that causes scarring of the lungs. The disease is associated with the usual interstitial pneumonia pattern, which was not yet fully recapitulated by an animal mo
Externí odkaz:
https://doaj.org/article/075a76af8de74da69694a75397345d3b
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-10 (2020)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a chronic and ultimately fatal disease characterized by a progressive decline in lung function. Fibrotic diseases, such as IPF, are characterized by uncontrolled activation of fibroblasts. Si
Externí odkaz:
https://doaj.org/article/272b9bb930cb4aff8fda163f7b4b353a
Autor:
Matthew Koslow, David Shitrit, Lilach Israeli‐Shani, Orit Uziel, Einat Beery, Alexandra Osadchy, Yael Refaely, Gali Epstein Shochet, Aliza Amiel
Publikováno v:
Thoracic Cancer, Vol 10, Iss 4, Pp 1009-1015 (2019)
A ground glass opacity (GGO) lung lesion may represent early stage adenocarcinoma, which has an excellent prognosis upon prompt surgical resection. However, GGO lesions have broad differential diagnoses, including both benign and malignant lesions. O
Externí odkaz:
https://doaj.org/article/4ab4162986954ede83350ff1e1d5bb3f
Autor:
Gali Epstein Shochet, Alon Pomerantz, David Shitrit, Becky Bardenstein-Wald, Kjetil Ask, Mark Surber, Noa Rabinowicz, Yair Levy, Sydney Benchetrit, Evgeny Edelstein, Tali Zitman-Gal
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 11 (2020)
Background and Aims: Idiopathic pulmonary fibrosis (IPF) is a common and severe form of pulmonary fibrosis. Nintedanib, a triple angiokinase inhibitor, is approved for treating IPF. Galectin 3 (Gal-3) activates a variety of profibrotic processes. Cur
Externí odkaz:
https://doaj.org/article/4d437238daf046e39b917a3ee3cc0e02
Autor:
Gali Epstein Shochet, Elizabetha Brook, Becky Bardenstein-Wald, Hanna Grobe, Evgeny Edelstein, Lilach Israeli-Shani, David Shitrit
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 11 (2020)
Background and objective: The term ‘fibroblast’ covers a heterogeneous cell population in idiopathic pulmonary fibrosis (IPF). The fibroblasts are considered as main effector cells, because they promote disease progression by releasing exaggerate
Externí odkaz:
https://doaj.org/article/26b9eaac590a4e77a43a0b9f2b3d6218
Autor:
Gali Epstein Shochet, Elizabetha Brook, Lilach Israeli-Shani, Evgeny Edelstein, David Shitrit
Publikováno v:
Respiratory Research, Vol 18, Iss 1, Pp 1-12 (2017)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis. Inflammatory cytokines play a significant role in IPF pathology. However, the fibroblast itself is also believed to be the primary effector i
Externí odkaz:
https://doaj.org/article/9733503f75cf4012ada39437efba731c
Autor:
Gali Epstein Shochet, Becky Bardenstein-Wald, Mary McElroy, Andrew Kukuy, Mark Surber, Evgeny Edelstein, Barak Pertzov, Mordechai Reuven Kramer, David Shitrit
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 7, p 3331 (2021)
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis. The IPF-conditioned matrix (IPF-CM) system enables the study of matrix–fibroblast interplay. While effective at slowing fibrosis, nintedanib has limitations and
Externí odkaz:
https://doaj.org/article/d502c9a183744b308a2b02b98bdb97fa
Publikováno v:
The Israel Medical Association journal : IMAJ. 24(7)
Autor:
Ori Wand, Daniel Gabbai, Gali Epstein Shochet, Alex Prokupetz, Tatiana Kats, Oded Ben-Ari, Keren Cohen-Hagai, Barak Gordon
Publikováno v:
Journal of cardiology.
While it appears not to affect healthy aviators' hearts, there are scarce data regarding the impact of high-performance flights on aviators with mitral valve prolapse (MVP).A retrospective, comparative cohort study of military aviators with MVP. Subj